We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App





World’s First AI-Powered Diagnostic Test Accurately Identifies Respiratory Viruses in Five Minutes

By LabMedica International staff writers
Posted on 09 Feb 2023

Current testing methods for respiratory viruses – such as a lateral flow test for COVID-19 – are limited to testing for just one infection or are either lab-based and time-consuming or fast and less accurate. More...

Now, a world-first diagnostic test powered by artificial intelligence (AI) that can identify known respiratory viruses within five minutes from just one nasal or throat swab could replace the current testing methods.

The ground-breaking virus detection and identification methodology has been described in a paper published in ACS Nano by researchers at University of Oxford (Oxford, UK). The paper demonstrates how machine learning can significantly improve the efficiency, accuracy and time required to identify different types of viruses, as well as differentiate between the strains. The technology combines molecular labeling, computer vision and machine learning to create a universal diagnostic imaging platform that looks directly at a patient sample and identifies which pathogen is present within seconds – similar to facial recognition software, but for germs.

In preliminary studies, the researchers have shown that the test can identify the COVID-19 virus in patient samples and further research determined that the test could be used for diagnosing multiple respiratory infections. In a study to validate the new method that uses AI software to identify viruses, the researchers began by labeling viruses with single-stranded DNA in more than 200 clinical samples. The images of labeled samples were captured using a commercial fluorescence microscope and processed by custom machine-learning software that is trained to recognize specific viruses by analyzing their fluorescence labels, which show up differently for each virus due to their varying surface size, shape and chemistry. The study showed that the technology is capable of rapidly identifying different types and strains of respiratory viruses, including flu and COVID-19, within five minutes and with an accuracy of >97%.

“Our simplified method of diagnostic testing is quicker and more cost-effective, accurate and future proof than any other tests currently available,” said Dr. Nicole Robb from the University of Warwick and Visiting Lecturer at Oxford’s Department of Physics. “If we want to detect a new virus, all we need to do is retrain the software to recognize it, rather than develop a whole new test. Our findings demonstrate the potential for this method to revolutionize viral diagnostics and our ability to control the spread of respiratory illnesses.”

Related Links:
University of Oxford


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Serological Pipet Controller
PIPETBOY GENIUS
New
Shaking Incubator
Corning LSE 71L
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Schematic overview of the deep learning-based circulating exosome analysis for lung cancer detection (Photo courtesy of Chuan Xu, Cheng Jiang)

Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer

Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more

Pathology

view channel
Image: The Aiforia Breast Cancer Grading AI solution is CE-IVD marked (Photo courtesy of Aiforia Technologies)

Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy

Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.